Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: A better view of the J3 case. Mark
7
Dec 25, 2008 09:28AM

Dec 26, 2008 05:11AM

Dec 26, 2008 05:44AM
3
Dec 26, 2008 06:57AM
7
Dec 26, 2008 08:26AM
2
Dec 26, 2008 08:51AM
5
Dec 26, 2008 09:17AM
7
Dec 26, 2008 09:35AM
4
Dec 26, 2008 09:39AM
1
Dec 26, 2008 10:24AM
5
Dec 26, 2008 10:45AM
5
Dec 26, 2008 10:49AM
2
Dec 26, 2008 11:51AM
1
Dec 26, 2008 12:44PM

Dec 26, 2008 04:44PM

Dec 26, 2008 06:12PM
3
Dec 27, 2008 03:46AM
10
Dec 28, 2008 01:50PM

From the alliance website:

"In light of these early, important licensing endorsements by Intel and AMD, the market demanded greater clarity and certainty...........

The MMP Portfolio Licensing Program therefore focuses licensing requirements and royalty collection on the finished "system-level" product. A royalty-free MMP Portfolio license is also available to manufacturers of chips and other unfinished goods.

It seems they are saying there are two types of licenses, and if they stated such in their original contracts to Intel and AMD then they could indeed double dip. I believe the case that you are referring to, the Supreme Courts decision, even stated that had LG made such specific conditions in their contract then it would be allowed, but they hadn't. What we need to determine is whether TPL and Patriot had that kind of wording in their contracts to Intel and AMD.

Regardless of what they did with Intel and AMD any future manufacturers will have that condition in their licensing agreements. The manufacturers can either bear the cost of the entire industry segment, or purchase a manufacturing license and let the system manufacturers ( the Dells etc) pay as they go. As long as the intent is specific it would not conflict with Quanta vs LG decision.

3
Dec 31, 2008 07:21AM
Share
New Message
Please login to post a reply